Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY-D Immunogenicity in Frequent Platelet Donors
NCT04224311Phase 4Unknown
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2020
- Primary completion
- Oct 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of meningococcal A conjugate vaccine in meningococcal disease (3 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Seroresponse of vaccine at 6 months. Status: unknown.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT04224311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04224311.